清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Pathogenetic role of IL-4 and IL-13 in atopic dermatitis: The inhibitory pathways

作者
D. Sh. Macharadze
出处
期刊:Медицинская иммунология [SPb RAACI]
卷期号:27 (2): 287-296
标识
DOI:10.15789/1563-0625-pro-3070
摘要

The review article is devoted to the two key Th2 cytokines, IL-4 and IL-13, which are directly involved in the immunopathogenesis of atopic dermatitis (AD). The identification of IL-4 and IL-13 in AD was first reported by Q. Hamid et al. in 1994. Since then, a number of studies have appeared confirming the relationship of these Th2 cytokines with disruption of the skin epidermal barrier; a decrease in skin immune response due to inhibited expression of antimicrobial peptides against Staphylococcus aureus, etc. The convincing studies also confirm a relationship with IL-4/IL-13 to such clinical manifestations of ADs as skin infections, as well as inflammation, lichenification and itching of the skin. The role of IL-4 and IL-13 is also confirmed by clinical studies, which indicate a beneficial effect of drugs inhibiting these cytokines on the relief of skin symptoms in atopic dermatitis (itching, rashes). The IL-4 and IL-13 are shown to connect the JAK/STAT signaling pathway due to the common α-subunit of IL-4 receptor (IL-4Rα). Importantly, IL-4, IL-13 and other cytokines (including IL-31) are capable of activating the sensory neurons, thus being often considered potent pruritogens. The article also discusses issues related to the role of the JAK/STAT signaling pathway and, in particular, the JAK1 protein in development of atopic dermatitis. As based on pathogenetic significance of IL-4 and IL-13, drugs have recently been developed that block their activity and, thereby, affect important molecular pathways of the AD development. These drugs are classified as systemic medications which include, e.g., (1) biological therapy (dupilumab, the first monoclonal IgG4 antibody), which blocks IL-4Rα and, thereby, suppresses the IL-4/IL-13 axis, and (2). Janus kinase (JAK) inhibitors or small-molecule agents. Currently, some Janus kinase inhibitors, e.g., abrocitinib, upadacitinib, and barocitinib, are available in Russia. Clinical studies show that both biological therapy and small molecules have an immunomodulatory effect on the course of atopic dermatitis. The review briefly presents the main data of recent meta-analyses on the comparative characteristics of biotherapy and usage of Janus kinase inhibitors in this disorder.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
龙弟弟完成签到 ,获得积分10
1秒前
6秒前
体贴的小霜完成签到,获得积分10
6秒前
魔幻雅柔完成签到,获得积分10
12秒前
Zephyr完成签到 ,获得积分10
13秒前
15秒前
清新的方盒完成签到 ,获得积分10
17秒前
20秒前
Jannatul完成签到,获得积分10
22秒前
25秒前
pericles发布了新的文献求助10
26秒前
35秒前
44秒前
53秒前
ubless607的应助被科研通管家采纳,获得10
55秒前
怕黑的驳完成签到,获得积分10
55秒前
老猫322完成签到 ,获得积分10
56秒前
58秒前
英俊的傲珊完成签到,获得积分10
1分钟前
1分钟前
小橙子完成签到 ,获得积分10
1分钟前
qaplay完成签到 ,获得积分0
1分钟前
1分钟前
白嫖论文完成签到 ,获得积分10
1分钟前
1分钟前
CHME完成签到 ,获得积分10
1分钟前
Z小姐完成签到 ,获得积分10
1分钟前
jiayouliyi完成签到 ,获得积分10
1分钟前
1分钟前
玛卡巴卡爱吃饭完成签到 ,获得积分0
1分钟前
1分钟前
炙热迎天完成签到,获得积分10
1分钟前
SMG完成签到 ,获得积分10
1分钟前
qqq完成签到 ,获得积分0
1分钟前
zy完成签到 ,获得积分10
1分钟前
1分钟前
大意的之柔完成签到,获得积分10
2分钟前
2分钟前
2分钟前
失之东隅完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185496
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783092
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481346